Concepedia

Munjid Al Harthy

MA

3

Publications

124

Citations

3

H-Index

2020

Active since

Affiliations

National Institutes of Health Clinical Center(Current)

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Frederick National Laboratory for Cancer Research

National Cancer Institute

National Institutes of Health

Munjid Al Harthy is an author at National Institutes of Health Clinical Center specializing in cancer therapeutics, oncology, and tumor biology.

Top concepts

Publications per year

2020–2025

3

Publications

3

Results from a phase II study of bevacizumab and erlotinib in subjects with advanced hereditary leiomyomatosis and renal cell cancer (HLRCC) or sporadic papillary renal cell cancer.

Ramaprasad Srinivasan, Sandeep Gurram, Munjid Al Harthy et al. · Journal of Clinical Oncology · 2020 · 93 citations

, , +19

Bevacizumab and Erlotinib in Hereditary and Sporadic Papillary Kidney Cancer

Ramaprasad Srinivasan, Sandeep Gurram, Eric A. Singer et al. · New England Journal of Medicine · 2025 · 19 citations

Cabozantinib plus docetaxel and prednisone in metastatic castration‐resistant prostate cancer

Ravi A. Madan, Fatima Karzai, Munjid Al Harthy et al. · British Journal of Urology · 2020 · 12 citations · Full text

Rows per page

1–3 of 3